
Regenerative medicine for geographic atrophy
AMD
News
Research and clinical trials
At the International Symposium on Ocular Pharmacology and Therapeutics (ISOPT), Lucia Lee Ferraro, MD, Director of IVEG, presented a study on hiPSC-derived RPE cell transplantation as a potential treatment for geographic atrophy. Regenerative therapy is a hope for the many patients with atrophic AMD, a condition for which there is currently no treatment.